PortfoliosLab logoPortfoliosLab logo
SMG vs. FLGT
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

SMG vs. FLGT - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in The Scotts Miracle-Gro Company (SMG) and Fulgent Genetics, Inc. (FLGT). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, SMG achieves a 14.91% return, which is significantly higher than FLGT's -37.00% return.


SMG

1D
-3.85%
1M
-4.60%
6M
4.41%
YTD
14.91%
1Y
10.94%
3Y*
1.54%
5Y*
-14.82%
10Y*
2.12%
ALL TIME*
7.26%

FLGT

1D
-18.11%
1M
-20.62%
6M
-36.83%
YTD
-37.00%
1Y
-10.69%
3Y*
-24.74%
5Y*
-29.08%
10Y*
ALL TIME*
6.14%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison


PositionAvg. Volume Value (2W)Avg. Volume Value (1M)Avg. Volume Value (3M)
$6.50M$5.58M$7.39M
$71.67M$69.95M$61.63M

SMG vs. FLGT - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
SMG
The Scotts Miracle-Gro Company
14.91%-8.01%8.28%36.92%-68.81%-18.03%96.18%77.05%-41.00%14.46%
FLGT
Fulgent Genetics, Inc.
-37.00%42.23%-36.11%-2.92%-70.39%93.07%303.88%306.94%-27.63%-62.14%

Correlation

The correlation between SMG and FLGT is 0.15, which is low. Their historical price movements had little consistent relationship.


Correlation
Correlation (1Y)
Focuses on recent behavior, but can change the most.

0.15

Correlation (3Y)
Balances recent behavior with more history.

0.25

Correlation (5Y)
Shows whether the relationship held over a longer period.

0.31

Correlation (All Time)
Calculated using the full available price history since Sep 29, 2016

0.21

The correlation between SMG and FLGT shifts across timeframes, from 0.15 (1 year) to 0.31 (5 years), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

SMG:

$3.82B

FLGT:

$470.03M

EPS

SMG:

$1.12

FLGT:

-$2.80

PS Ratio

SMG:

1.14

FLGT:

1.54

Total Revenue (TTM)

SMG:

$3.37B

FLGT:

$323.93M

Gross Profit (TTM)

SMG:

$1.09B

FLGT:

$115.26M

EBITDA (TTM)

SMG:

$434.60M

FLGT:

-$72.79M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

SMG vs. FLGT — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

SMG
SMG Risk / Return Rank: 5353
Overall Rank
SMG Sharpe Ratio Rank: 5555
Sharpe Ratio Rank
SMG Sortino Ratio Rank: 4949
Sortino Ratio Rank
SMG Omega Ratio Rank: 4848
Omega Ratio Rank
SMG Calmar Ratio Rank: 5757
Calmar Ratio Rank
SMG Martin Ratio Rank: 5858
Martin Ratio Rank

FLGT
FLGT Risk / Return Rank: 4343
Overall Rank
FLGT Sharpe Ratio Rank: 4242
Sharpe Ratio Rank
FLGT Sortino Ratio Rank: 4242
Sortino Ratio Rank
FLGT Omega Ratio Rank: 4747
Omega Ratio Rank
FLGT Calmar Ratio Rank: 4242
Calmar Ratio Rank
FLGT Martin Ratio Rank: 4242
Martin Ratio Rank
The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

SMG vs. FLGT - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for The Scotts Miracle-Gro Company (SMG) and Fulgent Genetics, Inc. (FLGT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


SMGFLGTDifference
Sharpe ratioReturn per unit of total volatility

+0.32

Sortino ratioReturn per unit of downside risk

+0.29

Omega ratioGain probability vs. loss probability

1.08

1.07

+0.01

Calmar ratioReturn relative to maximum drawdown

0.48

-0.07

+0.54

Martin ratioReturn relative to average drawdown

1.00

-0.12

+1.13

SMG vs. FLGT - Sharpe Ratio Comparison

The current SMG Sharpe Ratio is 0.26, which is higher than the FLGT Sharpe Ratio of -0.06. The chart below compares the historical Sharpe Ratios of SMG and FLGT, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

SMG vs. FLGT - Drawdown Comparison

The maximum SMG drawdown since its inception was -83.55%, smaller than the maximum FLGT drawdown of -92.50%. Use the drawdown chart below to compare losses from any high point for SMG and FLGT.


Loading charts...

Drawdown Indicators


SMGFLGTDifference

Max Drawdown

Largest peak-to-trough decline

-83.55%

-92.50%

+8.95%

Max Drawdown (1Y)

Largest decline over 1 year

-20.12%

-55.30%

+35.18%

Max Drawdown (3Y)

Largest decline over 3 years

-47.42%

-64.54%

+17.12%

Max Drawdown (5Y)

Largest decline over 5 years

-76.67%

-87.56%

+10.89%

Max Drawdown (10Y)

Largest decline over 10 years

-83.55%

Current Drawdown

Current decline from peak

-68.50%

-91.00%

+22.50%

Average Drawdown

Average peak-to-trough decline

-22.18%

-61.99%

+39.81%

Ulcer Index

Depth and duration of drawdowns from previous peaks

9.53%

30.18%

-20.65%

Volatility

SMG vs. FLGT - Volatility Comparison

The current volatility for The Scotts Miracle-Gro Company (SMG) is 14.53%, while Fulgent Genetics, Inc. (FLGT) has a volatility of 21.41%. This indicates that SMG experiences smaller price fluctuations and is considered to be less risky than FLGT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


SMGFLGTDifference

Volatility (1M)

Calculated over the trailing 1-month period

14.53%

21.41%

-6.88%

Volatility (6M)

Calculated over the trailing 6-month period

30.08%

60.11%

-30.03%

Volatility (1Y)

Calculated over the trailing 1-year period

36.38%

60.38%

-24.00%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

46.85%

50.92%

-4.07%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

40.72%

75.46%

-34.74%

Dividends

SMG vs. FLGT - Dividend Comparison

SMG's dividend yield for the trailing twelve months is around 4.02%, while FLGT has not paid dividends to shareholders.


PositionTTM20252024202320222021202020192018201720162015
FLGT
Fulgent Genetics, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
SMG
The Scotts Miracle-Gro Company
4.02%4.52%3.98%4.14%5.43%1.59%3.72%2.13%3.51%1.93%2.03%2.85%

Financials

SMG vs. FLGT - Financials Comparison

This section allows you to compare key financial metrics between The Scotts Miracle-Gro Company and Fulgent Genetics, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items

SMG vs. FLGT - Profitability Comparison

The chart below illustrates the profitability comparison between The Scotts Miracle-Gro Company and Fulgent Genetics, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

SMG - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, The Scotts Miracle-Gro Company reported a gross profit of 365.90M and revenue of 1.17B. Therefore, the gross margin over that period was 31.2%.

FLGT - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Fulgent Genetics, Inc. reported a gross profit of 25.68M and revenue of 85.39M. Therefore, the gross margin over that period was 30.1%.

SMG - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, The Scotts Miracle-Gro Company reported an operating income of 169.60M and revenue of 1.17B, resulting in an operating margin of 14.5%.

FLGT - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Fulgent Genetics, Inc. reported an operating income of -29.72M and revenue of 85.39M, resulting in an operating margin of -34.8%.

SMG - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, The Scotts Miracle-Gro Company reported a net income of 103.60M and revenue of 1.17B, resulting in a net margin of 8.8%.

FLGT - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Fulgent Genetics, Inc. reported a net income of -29.53M and revenue of 85.39M, resulting in a net margin of -34.6%.


Frequently Asked Questions


SMG and FLGT have a correlation of 0.15, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

FLGT has higher volatility (21.41%) compared to SMG (14.53%). In terms of maximum drawdown, SMG dropped -83.55% vs FLGT's -92.50%.

SMG currently has the higher Sharpe Ratio (0.26 vs -0.06), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for SMG and FLGT

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer